DDW_Sartorius_Event_Logos_400px copy
 
Daryl Cole_speaker_image_200px

The value of stem cells in laboratory and clinical research has been clearly demonstrated through numerous studies, showcasing their potential as models for a wide range of diseases and therapeutic developments. The inherent flexibility of stem cells allows for the development of various tissue types from a single, highly proliferative base cell type. Differentiation of induced pluripotent stem cells (iPSCs) into somatic tissues requires specific conditions tailored to the desired tissue type.

In this webinar, we describe the process of differentiating human iPSCs into hepatocytes using three distinct media types, each supplemented with specific growth factors and cytokines at key stages of differentiation. This method provides a relatively straightforward approach to producing mature hepatic cells, enabling the generation of human hepatic organoids from these source cells. This demonstrates a robust method for unlimited organoid development.

We outline a simple, standardised, and robust workflow that utilises Research Use Only (RUO) Growth Factors and Cytokines, combined with high-throughput screening cytometry for phenotypic characterisation and live-cell analysis for monitoring cell growth.

This approach simplifies the generation of functional hepatic cells and organoids from iPSCs, facilitating drug discovery, development, and toxicity studies. 


Key Takeaways:

  • How to differentiate iPSCs into Hepatic lineage cells and organoids
  • Best practices for monitoring differentiation, while confirming lineage and function
  • Dissociation of complex 3D structures into healthy single cells for analysis
  • How Sartorius products can aid in the simplification and development of robust protocols for organoid production 

    An audience Q&A session with the presenter follows the webinar presentation.

Watch the webinar on-demand now!

Watch the Webinar